Front Pharmacol
Frontiers in Pharmacology, with ISSN 1663-9812, is a leading open-access journal dedicated to the broad and interdisciplinary field of pharmacology. Published by Frontiers Media SA, the journal serves as a premier platform for disseminating high-quality, peer-reviewed research across all areas of pharmacology, including drug discovery, development, clinical therapeutics, and toxicology. Its scope encompasses fundamental and translational studies, embracing topics such as pharmacokinetics, pharmacodynamics, molecular pharmacology, ethnopharmacology, and the pharmacology of natural products. The journal welcomes a diverse array of article types, including Original Research, Systematic Reviews, Mini Reviews, Methods, Perspectives, and Clinical Trial reports, ensuring comprehensive coverage of both empirical findings and theoretical advances. The target audience is equally broad, comprising academic researchers, pharmaceutical scientists, clinical pharmacologists, medical practitioners, and regulatory professionals who seek timely access to cutting-edge developments. A notable feature is its rigorous open-access model, which ensures all published content is freely available to the global scientific community, thereby maximizing visibility and impact. With an Impact Factor of 5.9880 for 2026, the journal holds a distinguished position within the JCR Quartile Q1, reflecting its high citation influence and consistent scholarly relevance. This standing underscores Frontiers in Pharmacology as a highly respected and influential venue in the field, attracting significant contributions from leading research groups worldwide and fostering open dialogue on innovative therapeutic strategies and drug safety.